Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Skyline Medical to Hold Business Update Conference Call on March 15, 2017
MINNEAPOLIS, March 09, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announced today that management will hold a conference call on March 15,
View HTML
Toggle Summary Skyline Medical Awarded Innovative Technology Contract from Vizient, Inc. for STREAMWAY® System
MINNEAPOLIS, March 01, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"),producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal has received an Innovative Technology contract  from Vizient, Inc
View HTML
Toggle Summary Skyline Medical Announces Exercise of Over-Allotment Option by Underwriter
MINNEAPOLIS, Feb. 22, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today announced that Dawson James Securities, Inc., the underwriter of its
View HTML
Toggle Summary Skyline Medical, Inc. Compliant with All Nasdaq Listing Criteria
MINNEAPOLIS, Feb. 17, 2017 (GLOBE NEWSWIRE) -- Skyline Medical, Inc. (NASDAQ:SKLN) today announced that it has received formal notice from The NASDAQ Stock Market LLC ("Nasdaq") indicating that the Company has evidenced full compliance with all requirements for continued listing on The Nasdaq
View HTML
Toggle Summary Skyline Medical Stockholders Approve Proposal to Increase Shares Outstanding
MINNEAPOLIS, Jan. 26, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces that stockholders have approved an amendment of the Company's
View HTML
Toggle Summary Skyline Medical Announces Pricing of Public Offering of Common Stock and Warrants View HTML
Toggle Summary Skyline Medical to Hold Business Update Conference Call on January 19, 2017
MINNEAPOLIS, Jan. 12, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announced today that management will hold a conference call on January 19, 2017
View HTML
Toggle Summary Skyline Medical Receives Requested Extension from Nasdaq Panel
MINNEAPOLIS, Dec. 29, 2016 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces the Nasdaq Hearings Panel (the "Panel") has granted the Company's
View HTML
Toggle Summary Skyline Medical Names Carl Schwartz Chief Executive Officer, Appoints Richard Gabriel to Board of Directors
MINNEAPOLIS, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today announced changes in executive management and the board of
View HTML
Toggle Summary Skyline Medical Vice President of Sales Interviewed on WPSL-AM 1590 MONEYINFO Program
Peter Alex Discusses Canadian Marketing and Distribution Plans for STREAMWAY® System
View HTML